HMGA2 and breast carcinoma: Compared with the blank and NC groups, cell proliferation in breast cancer was inhibited in the miR-98 mimics and siRNA-HMGA2 groups (all P<0.05), while enhanced levels were observed in the miR-98 inhibitors group (P<0.05).